Feature Channels: Diabetes

Filters close
access_time Embargo lifts in 2 days
Embargo will expire: 1-Jun-2020 11:00 AM EDT Released to reporters: 28-May-2020 1:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Jun-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 2-Jun-2020 2:30 PM EDT Released to reporters: 28-May-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 2-Jun-2020 2:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Jun-2020 11:00 AM EDT Released to reporters: 28-May-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Jun-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Jun-2020 12:00 PM EDT Released to reporters: 28-May-2020 9:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 1-Jun-2020 12:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: No-Deductible Preventive Drugs Lower Costs, Increase Medication Use for Low-Income Diabetes Patients
Released: 27-May-2020 10:05 AM EDT
No-Deductible Preventive Drugs Lower Costs, Increase Medication Use for Low-Income Diabetes Patients
Wolters Kluwer Health: Lippincott Williams and Wilkins

For patients with diabetes – especially those with lower incomes – preventive drug lists (PDLs) of essential medications available with no deductible can reduce out-of-pocket costs while increasing use of important treatments, reports a study in a June supplement to Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Newswise: First map of proinsulin’s “social network” reveals new drug target for type 2 diabetes
Released: 27-May-2020 8:00 AM EDT
First map of proinsulin’s “social network” reveals new drug target for type 2 diabetes
Sanford Burnham Prebys Medical Discovery Institute

Scientists at Sanford Burnham Prebys Medical Discovery Institute have mapped for the first time the vast network of proteins that interact with proinsulin, the protein the body normally processes into insulin. The study, published in Diabetes, also revealed one protein—called PRDX4—that may be essential for proinsulin folding and insulin production. The research suggests that boosting PRDX4 levels may be a novel therapeutic approach to improving the health of people with diabetes.

Released: 22-May-2020 2:30 PM EDT
Blood test could predict diabetes years before it strikes
University of Toronto

Scientists have identified metabolites in the blood that accurately predict whether a woman will develop type 2 diabetes after experiencing a transient form of illness during pregnancy.

Newswise: A sole mate to prevent diabetic foot ulcers
Released: 21-May-2020 6:10 PM EDT
A sole mate to prevent diabetic foot ulcers
UT Southwestern Medical Center

A new cooling insole developed by UT Southwestern scientists reduced the foot temperature of patients with diabetic neuropathy by several degrees, diminishing a significant risk factor for diabetic foot ulcers.

Newswise: Drug combination could eliminate side effects of once-popular diabetes treatment
Released: 20-May-2020 2:45 PM EDT
Drug combination could eliminate side effects of once-popular diabetes treatment
UT Southwestern Medical Center

A new UT Southwestern study shows how an effective but largely abandoned treatment for Type 2 diabetes could be used again in combination with another drug to eliminate problematic side effects.

Newswise: theoarvanitis.jpg
Released: 14-May-2020 8:55 AM EDT
Patients prefer their consent to share their data and to manage it digitally
University of Warwick

A group of patients with diabetes were surveyed on their understanding of the consent process to have their medical data shared with digital platforms offering innovations to the management of their condition.


Showing results

110 of 10

close
0.89999